Your browser doesn't support javascript.
loading
Can oncologists predict survival for patients with progressive disease after standard chemotherapies?
Taniyama, T K; Hashimoto, K; Katsumata, N; Hirakawa, A; Yonemori, K; Yunokawa, M; Shimizu, C; Tamura, K; Ando, M; Fujiwara, Y.
Affiliation
  • Taniyama TK; Department of Breast Oncology and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Hashimoto K; Department of Breast Oncology and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Katsumata N; Medical Oncology, Musashikosugi Hospital, Nippon Medical School, Kanagawa, Japan.
  • Hirakawa A; Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan.
  • Yonemori K; Department of Breast Oncology and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Yunokawa M; Department of Breast Oncology and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Shimizu C; Department of Breast Oncology and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Tamura K; Department of Breast Oncology and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Ando M; Department of Clinical Oncology, Aichi Cancer Center, Nagoya, Japan.
  • Fujiwara Y; Department of Breast Oncology and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Curr Oncol ; 21(2): 84-90, 2014 Apr.
Article in En | MEDLINE | ID: mdl-24764697

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Curr Oncol Year: 2014 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Curr Oncol Year: 2014 Document type: Article Affiliation country: